InMed Pharmaceuticals, Inc. (INM)
1.43
-0.03
(-2.05%)
USD |
NASDAQ |
Aug 24, 16:00
1.44
+0.01
(+0.70%)
After-Hours: 20:00
InMed Pharmaceuticals Price : 1.43 for Aug. 24, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 24, 2026 | 1.48 | 1.61 | 1.41 | 1.43 | 164410.0 |
| Aug 21, 2026 | 1.58 | 1.615 | 1.45 | 1.46 | 71608.00 |
| Aug 20, 2026 | 1.57 | 1.65 | 1.54 | 1.58 | 63936.00 |
| Aug 19, 2026 | 1.46 | 1.632 | 1.45 | 1.59 | 86112.00 |
| Aug 18, 2026 | 1.49 | 1.64 | 1.44 | 1.44 | 269128.0 |
| Aug 17, 2026 | 1.47 | 1.54 | 1.430 | 1.46 | 73930.00 |
| Aug 14, 2026 | 1.448 | 1.50 | 1.44 | 1.47 | 40717.00 |
| Aug 13, 2026 | 1.45 | 1.458 | 1.410 | 1.43 | 23996.00 |
| Aug 12, 2026 | 1.45 | 1.48 | 1.41 | 1.44 | 38615.00 |
| Aug 11, 2026 | 1.43 | 1.47 | 1.40 | 1.46 | 56585.00 |
| Aug 10, 2026 | 1.35 | 1.500 | 1.35 | 1.41 | 130835.0 |
| Aug 07, 2026 | 1.43 | 1.485 | 1.42 | 1.47 | 54554.00 |
| Aug 06, 2026 | 1.42 | 1.46 | 1.40 | 1.43 | 43332.00 |
| Aug 05, 2026 | 1.48 | 1.50 | 1.40 | 1.40 | 118412.0 |
| Aug 04, 2026 | 1.47 | 1.525 | 1.467 | 1.49 | 71277.00 |
| Aug 03, 2026 | 1.47 | 1.50 | 1.425 | 1.46 | 63069.00 |
| Jul 31, 2026 | 1.55 | 1.56 | 1.440 | 1.47 | 258486.0 |
| Jul 30, 2026 | 1.67 | 1.725 | 1.48 | 1.50 | 261721.0 |
| Jul 29, 2026 | 1.66 | 1.70 | 1.62 | 1.67 | 223086.0 |
| Jul 28, 2026 | 1.62 | 1.725 | 1.61 | 1.67 | 140461.0 |
| Jul 27, 2026 | 1.66 | 1.80 | 1.60 | 1.64 | 337950.0 |
| Jul 24, 2026 | 1.88 | 1.90 | 1.69 | 1.71 | 332283.0 |
| Jul 23, 2026 | 1.65 | 1.95 | 1.60 | 1.85 | 1.316M |
| Jul 22, 2026 | 2.15 | 2.33 | 1.49 | 1.66 | 52.10M |
| Jul 21, 2026 | 1.53 | 1.54 | 1.50 | 1.54 | 10286.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| NervGen Pharma Corp. | 2.00 |
| Milestone Pharmaceuticals, Inc. | 1.04 |
| Clearmind Medicine, Inc. | 1.68 |
| Lexaria Bioscience Corp. | 10.54 |
| Target Group, Inc. (Canada) | 0.0010 |
Price Related Metrics
| PS Ratio | 1.538 |
| Price to Book Value | 0.6877 |
| Earnings Yield | -180.1% |
| Market Cap | 4.739M |